Trial Profile
A phase II trial of Heartcel in advanced heart failure patients at high risk of incomplete revascularization
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2017
Price :
$35
*
At a glance
- Drugs CLXR 001 (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Sponsors Celixir
- 12 Jun 2017 New trial record